Glenda M. Halliday

96.4k citations

661 papers · 51.2k indexed · 14 hit papers · h-index 104

Neurology top 0.01%
- Parkinson's Disease Mechanisms and Treatments 312
- Neurological disorders and treatments 122
- Amyotrophic Lateral Sclerosis Research 93
- Neurological diseases and metabolism 72
Neurology top 0.01%
- Parkinson's Disease Mechanisms and Treatments 312
- Neurological disorders and treatments 122
- Amyotrophic Lateral Sclerosis Research 93
- Neurological diseases and metabolism 72
Cellular and Molecular Neuroscience top 0.02%
- Nuclear Receptors and Signaling 55
- Neuroscience and Neuropharmacology Research 47
Physiology top 0.02%
- Alzheimer's disease research and treatments 202
Psychiatry and Mental health top 0.1%
- Dementia and Cognitive Impairment Research 79

Co-authors: Jillian J. Kril Anthony E. Lang Werner Poewe José Á. Obeso John G. Morris Charles H. Adler M. A. Hely C. Warren Olanow
Cited by: Neurology Cellular and Molecular Neuroscience
Journals: Movement Disorders (51 papers)Acta Neuropathologica (35 papers)Brain (30 papers)
Partner nations: Australia United States United Kingdom

In The Last Decade

Glenda M. Halliday

641 papers receiving 50.3k citations

Hit Papers

14 papers align trajectories log scale

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

2022 Nature Reviews Disease Primers
2021 Nature Reviews Disease Primers
2017 Nature reviews. Neuroscience
2017 Nature Reviews Disease Primers
2015 Movement Disorders
2015 Movement Disorders
2015 Proceedings of the National Academy of Sciences
2014 Brain
2013 Brain
2010 Nature Medicine
2009 The Lancet Neurology
2008 Movement Disorders
2001 Annals of Neurology
1987 Brain Research Reviews

Peers

Countries citing papers authored by Glenda M. Halliday

Since Specialization

Citations

This map shows the geographic impact of Glenda M. Halliday's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Glenda M. Halliday with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Glenda M. Halliday more than expected).

Fields of papers citing papers by Glenda M. Halliday

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Glenda M. Halliday. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Glenda M. Halliday. The network helps show where Glenda M. Halliday may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Glenda M. Halliday, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Glenda M. Halliday Line = papers co-authored together Glenda M. Halliday links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	Human Endogenous Retrovirus K in Astrocytes Is Altered in Parkinson's Disease Movement Disorders ·YuHong Fu,Marion Calvo,Phạm Thị Thanh Trúc Phạm Thị Thanh Trúc,Katherine Phan,Glenda M. Halliday,Nicolas Dzamko,Woojin S. Kim	2025	3
2	Dysregulation of Monounsaturated Fatty Acids is Related to α‐Synuclein in Multiple System Atrophy Movement Disorders ·汤允昭,YuHong Fu,Russell Pickford,Qi Cheng,Yue Yang,Simon J.G. Lewis,Nicolas Dzamko,Glenda M. Halliday,Woojin S. Kim	2025	1
3	Distinct AQP4 Alterations in Movement Disorders with Primary Synucleinopathy Movement Disorders ·臧坚东,Onur Tanglay,Fong‐Chin Su,Hongyun Li,Jun Liu,Woojin S. Kim,Glenda M. Halliday,YuHong Fu	2025	1
4	Standardised TruAI Automated Quantification of Intracellular Neuromelanin Granules in Human Brain Tissue Sections Neuropathology and Applied Neurobiology ·Cati Poulos,Ms. Sandra Fabricatore,Zac Chatterton,Yucong Hua,Maura Hearden Fehlner,Joan Compte,YuHong Fu,Miquel Vila,Glenda M. Halliday	2025	0
5	A protective role of ABCA5 in response to elevated sphingomyelin levels in Parkinson’s disease npj Parkinson s Disease ·YuHong Fu,Russell Pickford,Jasmin Galper,Katherine Phan,Ping Wu,Hongyun Li,Young‐Bum Kim,Nicolas Dzamko,Glenda M. Halliday,Woojin S. Kim	2024	9
6	Prediction of motor and non-motor Parkinson’s disease symptoms using serum lipidomics and machine learning: a 2-year study npj Parkinson s Disease ·Jasmin Galper,Giorgia Mori,Gordon McDonald,郑月玲,Russell Pickford,Simon J.G. Lewis,Glenda M. Halliday,Woojin S. Kim,Nicolas Dzamko	2024	5
7	ATP-binding cassette transporters as possible targets for the intervention of neurodegenerative diseases Neural Regeneration Research ·Hiu Chuen Lok,Glenda M. Halliday,Woojin S. Kim	2023	2
8	Distribution Patterns of Astrocyte Populations in the Human Cortex Neurochemical Research ·Shelley L. Forrest,Eri,A. Sadeghi Looyea,Hosoya Takiko,Sciacchitano,Endeshaw Assefa,J Gross,Lars M. Ittner,Glenda M. Halliday,Jillian J. Kril	2022	17
9	Examining the presence and nature of delusions in Alzheimer's disease and frontotemporal dementia syndromes International Journal of Geriatric Psychiatry ·Fiona Kumfor,Shinichi Okajima,Jessica L. Hazelton,Cristian E. Leyton,Л. Я. Климуть,Emma Devenney,H Fabian,Robyn Langdon,Eneida Mioshi,John B. Kwok,Carol Dobson‐Stone,Glenda M. Halliday,Olivier Piguet,John R. Hodges,Ramón Landín-Romero	2022	3
10	Increased unsaturated lipids underlie lipid peroxidation in synucleinopathy brain Acta Neuropathologica Communications ·YuHong Fu,Ying He,Katherine Phan,Surabhi Bhatia,Russell Pickford,Ping Wu,Nicolas Dzamko,Glenda M. Halliday,Woojin S. Kim	2022	31
11	Multiple pathways of lipid dysregulation in amyotrophic lateral sclerosis Brain Communications ·Katherine Phan,Ying He,Surabhi Bhatia,Russell Pickford,Gordon McDonald,一郎石倉,Hannah C. Timmins,John R. Hodges,Olivier Piguet,Nicolas Dzamko,Glenda M. Halliday,Matthew C. Kiernan,Woojin S. Kim	2022	18
12	Loss of the metabolism and sleep regulating neuronal populations expressing orexin and oxytocin in the hypothalamus in amyotrophic lateral sclerosis Neuropathology and Applied Neurobiology ·Sanaz Gabery,Rebekah M. Ahmed,Jashelle Caga,Matthew C. Kiernan,Glenda M. Halliday,Åsa Petersén	2021	38
13	Accelerated loss of hypoxia response in zebrafish with familial Alzheimer’s disease-like mutation of presenilin 1 Human Molecular Genetics ·Morgan Newman,Seyyed Hani Moussavi Nik,Greg T. Sutherland,I. Secco,Woojin S. Kim,Glenda M. Halliday,Suman Jayadev,C. Smith,Angela S. Laird,Hulikere Jagdish Shwetha,Seong Man-Soon,Mifue Taminato,Michael Lardelli	2020	11
14	Uncovering pathophysiological changes in frontotemporal dementia using serum lipids Scientific Reports ·Katherine Phan,Ying He,Russell Pickford,Surabhi Bhatia,P. Sunder-Plassmann,John R. Hodges,Olivier Piguet,Glenda M. Halliday,Woojin S. Kim	2020	49
15	Evidence for α-synuclein prions causing multiple system atrophy in humans with parkinsonismbreakdown → Proceedings of the National Academy of Sciences ·Stanley B. Prusiner,Amanda L. Woerman,Daniel A. Mordes,Joel C. Watts,Ryan Rampersaud,David B. Berry,Smita S. Patel,Abby Oehler,Jennifer K. Lowe,Stephanie N. Kravitz,Daniel H. Geschwind,David V. Glidden,Glenda M. Halliday,Lefkos Middleton,Steve Gentleman,Lea T. Grinberg,Kurt Giles	2015	542
16	Time to redefine PD? Introductory statement of the MDS Task Force on the definition of Parkinson's disease Movement Disorders ·Daniela Berg,Ronald B. Postuma,Bastiaan R. Bloem,Piu Chan,Bruno Dubois,Thomas Gasser,Christopher G. Goetz,Glenda M. Halliday,John Hardy,Anthony E. Lang,Irene Litvan,Kenneth Marek,José Á. Obeso,Wolfgang H. Oertel,C. Warren Olanow,Werner Poewe,Matthew Stern,Günther Deuschl	2014	341
17	Variability in neuronal expression of dopamine receptors and transporters in the substantia nigra Movement Disorders ·Stefanie Reyes,Veronica Cottam,Deniz Kirik,Kay L. Double,Glenda M. Halliday	2013	23
18	Neuropathologic correlates of white matter hyperintensities Neurology ·Dina Knight,Glenda M. Halliday,Jillian J. Kril	2008	267
19	Preserved Cognition and Functional Independence after a Large Right Posterior Cerebral Artery Infarct: Longitudinal Clinical and Neuropathological Findings Neurocase ·Olivier Piguet,Hayley Bennett,Louise M. Waite,Jillian J. Kril,Helen Creasey,G. Anthony Broe,Glenda M. Halliday	2006	4
20	Degeneration of the centr� median-parafascicular complex in Parkinson's disease Annals of Neurology ·J. M. Henderson,Yashy Raghoo,Heidi Cartwright,Glenda M. Halliday	2000	126

About Glenda M. Halliday

Glenda M. Halliday is a scholar working on Neurology, Neurology and Cellular and Molecular Neuroscience, having authored 661 papers that have together received 51.2k indexed citations. Recurring topics across this work include Parkinson's Disease Mechanisms and Treatments (312 papers), Alzheimer's disease research and treatments (202 papers), Neurological disorders and treatments (122 papers), Amyotrophic Lateral Sclerosis Research (93 papers), Dementia and Cognitive Impairment Research (79 papers), Neurological diseases and metabolism (72 papers), Nuclear Receptors and Signaling (55 papers) and Neuroscience and Neuropharmacology Research (47 papers). The work is most often cited by research in Neurology (30.2k citations), Neurology (8.9k citations) and Cellular and Molecular Neuroscience (13.7k citations). Glenda M. Halliday has collaborated with scholars based in Australia, United States and United Kingdom. Frequent co-authors include Jillian J. Kril, Anthony E. Lang, Werner Poewe, José Á. Obeso, John G. Morris, Charles H. Adler, M. A. Hely, C. Warren Olanow, Klaus Seppi and Caroline M. Tanner. Their work appears in journals such as Movement Disorders, Acta Neuropathologica, Brain, Neurology and Neurobiology of Aging.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact